Feasibility of a New Technology for Isolating Circulating Tumour Cells

Conditions:   HER2-positive Metastatic Breast Cancer;   Ovarian Cancer;   Hormone-resistant Prostate Cancer;   Circulating Tumor Cell Intervention:   Procedure: Blood sample collection Sponsor:   Centre Oscar Lambret Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials